Natalizumab Interactions
There are 421 drugs known to interact with natalizumab, along with 4 disease interactions. Of the total drug interactions, 315 are major, 98 are moderate, and 8 are minor.
- View all 421 medications that may interact with natalizumab
- View natalizumab disease interactions (4)
Most frequently checked interactions
View interaction reports for natalizumab and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Acetylsalicylic Acid (aspirin)
- Activated Charcoal (charcoal)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Advil (ibuprofen)
- Advil PM (diphenhydramine / ibuprofen)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Andexxa (coagulation factor Xa)
- Avonex (interferon beta-1a)
- Celebrex (celecoxib)
- Claritin (loratadine)
- Concerta (methylphenidate)
- Copaxone (glatiramer)
- Klonopin (clonazepam)
- Lyrica (pregabalin)
- Mirena (levonorgestrel)
- Neurontin (gabapentin)
- Nuedexta (dextromethorphan / quinidine)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Paracetamol (acetaminophen)
- Paxil (paroxetine)
- Retinol (vitamin a topical)
- Ritalin (methylphenidate)
- Tecfidera (dimethyl fumarate)
- Vitamin B12 (cyanocobalamin)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
Natalizumab disease interactions
There are 4 disease interactions with natalizumab which include:
Report options
QR code containing a link to this page
More about natalizumab
- natalizumab consumer information
- Compare alternatives
- Reviews (102)
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
